跳至主要内容
临床试验/NCT02295267
NCT02295267已完成不适用

Molecular Analysis of IgE Antibodies in Walnut Allergic Patients

University of Zurich2 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
61
试验地点
2
主要终点
numbers of patients with walnut allergy

研究概览

简要总结

Accurate diagnosis of food allergy depends on the identification of the causative allergenic molecule(s). The proposed study intends to investigate and compare the pattern of IgE antibody sensitisation in walnut allergic subjects from three different regions of Europe (south (SEU) and central/north (C/NEU), to evaluate the diagnostic utility of a panel of novel allergen reagents.

详细描述

Accurate diagnosis of food allergy depends on the identification of the causative allergenic molecule(s). Thus, full characterization of the major allergens of walnut and their clinical importance is an important undertaking.

The proposed study intends to investigate and compare the pattern of IgE antibody sensitisation in walnut allergic subjects from three different regions of Europe (south (SEU) and central/north (C/NEU), to evaluate the diagnostic utility of a panel of novel allergen reagents.

With a view towards improved in vitro diagnostic methods, we intend to evaluate the diagnostic potential of recombinant walnut allergens in patients with walnut allergy confirmed by a positive provocation or supported by a convincing history of anaphylactic reaction(s) to walnut in the past, patients with pollinosis but no symptoms of walnut allergy and non-atopic control subjects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
1 Year 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Group A: positive case history of allergic reaction(s) to walnut
  • Group B: positive case history of allergy to birch, grass or olive pollen and no case history of allergic reaction(s) to walnut
  • Group C: no case history of atopic disease

排除标准

  • Known pregnancy
  • Breast-feeding of infant
  • Treatment with the following drugs (or shortest interval between last treatment and food challenge or SPT):
  • corticosteroids (2 weeks): applied systemically, to the nose or locally on the skin test area.
  • antihistamines (3 days) except hydroxyzine (10 days)
  • betablocker agents (1 day)
  • angiotensin converting enzyme inhibitors (2 days)
  • Any major organic or infectious disease

结局指标

主要结局

numbers of patients with walnut allergy

时间窗: December 2012 to November 2017, up to 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验